24/7 referral, consult, admission and neonatal transport assistance.
Clinical Guidelines and Decision Support
Children’s Minnesota has created a number of clinical practice guidelines for health professionals that highlight an evidence-based approach to the management of certain conditions in order to reduce unwarranted variation in care.
Guidelines are designed to apply to the bulk of patients with a given condition and should be adapted to individual patients based upon clinical judgment and individual situations. To assist providers with real-time decision making, most of the clinical guidelines at Children’s Minnesota consist of visual treatment algorithms/pathways, evidence-based ordersets, bibliographies and any applicable rules/alerts embedded within the electronic health record.
Appendicitis
Appendicitis ED Guideline
Appendicitis Surgical Guideline
Asthma
Asthma Exacerbation ED/Inpatient Guideline
Brief Resolved Unexplained Event (BRUE)
Brief Resolved Unexplained Event (BRUE) Guideline
Bronchiolitis
Cardiac Rehabilitation
Cardiac Rehabilitation Guideline
Cervical Spine Clearance
Cervical Spine Clearance Guideline
Clostridioides Difficile Infection (CDI)
C. Difficile Testing Guideline
C. Difficile Treatment Algorithm
COVID-19 (Coronavirus) Interim Guidelines
Coronavirus Interim Guidelines have not been through the formal guideline governance council review process but have been approved for interim use by clinical leaders. They should be viewed as interim guidelines and will be updated frequently as the situation evolves. Health care providers should also refer to external sources such as CDC.gov and the Minnesota Department of Health for additional resources for this dynamic situation.
Diagnostic testing strategy
Medical Management for patients with confirmed COVID-19
Suspected MIS-C management recommendations
Testing Algorithm: ED/Ambulatory
VTE Prophylaxis in COVID-19 patients
Croup
Croup Guideline: Age 3 Months-8 Years
Diabetes
Diabetic Ketoacidosis (DKA) Guideline
Diabetes DKA Overnight Admission St. Paul Housestaff Guideline
Fever ≥ 38.0°C (100.4°F) Without Obvious Source (Infant 1-60 Days)
Febrile Infant ED/Inpatient Guideline
Fever and Neutropenia
Fever and Neutropenia Treatment Guideline
Gastroenteritis
Acute Gastroenteritis Inpatient Guideline
Oral Rehydration Therapy – Less than 10kg Hmong, Somali, Spanish
Oral Rehydration Therapy – More than 10kg Hmong, Somali, Spanish
Jaundice
Hyperbilirubinemia in Newborn Infants ED Guideline
Kawasaki Disease
Classic Kawasaki Disease Guideline
Suspected Kidney Stone
Lab Guidelines
Clostridioides Difficile Infection (C-Diff) Testing Guideline
Measles
Menstrual Bleeding
Adolescent Symptomatic Acute Menstrual Bleeding – ED/Inpatient Guideline
Musculoskeletal (MSK)
Musculoskeletal (MSK) Infection Guideline
Nasal Brindle
Nasal Brindle (NB), Securement Device for NG/NJ Discharge Guideline
Neurogenic Bladder and Bowel
Neurogenic Bladder Guidelines
Neurogenic Bowel Guidelines
Open Fracture – Trauma
Antibiotic Prophylaxis in Patients with Open Fractures
Pharmacy
Key potentially inappropriate drugs in pediatrics: The Kids List
Pneumonia
Community Acquired Pneumonia Inpatient Guideline
Pneumonia Complicated by Empyema Inpatient Guideline
Pneumothorax
Primary Spontaneous Pneumothorax (PSP) Guideline
Rehabilitation
New Tracheostomy Recovery/Rehabilitation in PICU Guideline
Suspected Shunt Malfunction or Infection
Suspected Shunt Malfunction or Infection ED Guideline
Skin and Soft Tissue Infections (SSTIs)
Skin and Soft Tissue Infections Guideline
Speaking and Swallowing Valve (Passy-Muir)
Speaking and Swallowing Valve (Passy-Muir) Guideline: Inline Valve Trial
Stroke
Surgical Antibiotic Prophylaxis
Comprehensive Surgical Antibiotic Prophylaxis Guideline
Testicular Torsion
Evaluation of Potential Testicular Torsion Guideline
Urinary Tract Infections (UTI)
Urinary Tract Infections Guideline
Venous Thromboembolism (VTE)
VTE Prophylaxis in Trauma Patients (>12 years)
VTE Risk Stratification in Hospitalized Patients
Guidelines are updated periodically in keeping with emerging evidence. Each guideline contains an important disclaimer and users must proceed at their own risk accordingly: This guideline is designed for general use with most patients; each clinician should use his or her own independent judgment to meet the needs of each individual patient. This guideline is not a substitute for professional medical advice, diagnosis or treatment.
For more information, email [email protected].